| Tariq Mahmood, MD | |
|
7600 Lakeview Pkwy Ste 150, Rowlett, TX 75088-4387 | |
| (469) 800-3380 | |
| Not Available |
| Full Name | Tariq Mahmood |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 24 Years |
| Location | 7600 Lakeview Pkwy Ste 150, Rowlett, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063676534 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | D70271 (Maryland) | Secondary |
| 2084N0400X | Psychiatry & Neurology - Neurology | MD438762 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott And White Medical Center Lake Pointe | Rowlett, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthtexas Provider Network | 1355254210 | 1810 |
News Archive
Aggressive forms of bladder cancer involve the protein PODXL - a discovery that could hold the key to improved treatment, according to researchers at Lund University, Uppsala University and KTH in Sweden.
Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA(TM) (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology. Both trials succeeded in meeting their primary endpoints, which should make BENLYSTA eligible for approval by the U.S. Food and Drug Administration (FDA).
Patients with a suspected acute ischemic stroke who are taken by emergency medical services (EMS) directly to comprehensive stroke centers rather than the nearest stroke center for care are more likely to receive endovascular therapy, according to research led by investigators at the University of Chicago Medicine, in collaboration with local healthcare and emergency response groups.
A new way to use MRI scans may help determine whether dementia is Alzheimer's disease or another type of dementia, according to new research published in the December 26, 2012, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Interim study results indicate a certain drug combination treatment may suppress the hepatitis C virus more quickly than another.
› Verified 2 days ago
| Entity Name | Healthtexas Provider Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760488936 PECOS PAC ID: 1355254210 Enrollment ID: O20040727001187 |
News Archive
Aggressive forms of bladder cancer involve the protein PODXL - a discovery that could hold the key to improved treatment, according to researchers at Lund University, Uppsala University and KTH in Sweden.
Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA(TM) (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology. Both trials succeeded in meeting their primary endpoints, which should make BENLYSTA eligible for approval by the U.S. Food and Drug Administration (FDA).
Patients with a suspected acute ischemic stroke who are taken by emergency medical services (EMS) directly to comprehensive stroke centers rather than the nearest stroke center for care are more likely to receive endovascular therapy, according to research led by investigators at the University of Chicago Medicine, in collaboration with local healthcare and emergency response groups.
A new way to use MRI scans may help determine whether dementia is Alzheimer's disease or another type of dementia, according to new research published in the December 26, 2012, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Interim study results indicate a certain drug combination treatment may suppress the hepatitis C virus more quickly than another.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tariq Mahmood, MD 2100 Mack Blvd, Allentown, PA 18103-5622 Ph: (484) 884-0617 | Tariq Mahmood, MD 7600 Lakeview Pkwy Ste 150, Rowlett, TX 75088-4387 Ph: (469) 800-3380 |
News Archive
Aggressive forms of bladder cancer involve the protein PODXL - a discovery that could hold the key to improved treatment, according to researchers at Lund University, Uppsala University and KTH in Sweden.
Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA(TM) (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology. Both trials succeeded in meeting their primary endpoints, which should make BENLYSTA eligible for approval by the U.S. Food and Drug Administration (FDA).
Patients with a suspected acute ischemic stroke who are taken by emergency medical services (EMS) directly to comprehensive stroke centers rather than the nearest stroke center for care are more likely to receive endovascular therapy, according to research led by investigators at the University of Chicago Medicine, in collaboration with local healthcare and emergency response groups.
A new way to use MRI scans may help determine whether dementia is Alzheimer's disease or another type of dementia, according to new research published in the December 26, 2012, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Interim study results indicate a certain drug combination treatment may suppress the hepatitis C virus more quickly than another.
› Verified 2 days ago
Dr. Mark Yeakley, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7102 Shipp Rd, Rowlett, TX 75088 Phone: 972-463-6890 Fax: 972-463-6890 | |
Joseph S Jenike, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3005 Persimmon Pl, Rowlett, TX 75088 Phone: 972-412-0169 Fax: 972-412-0169 |